EMBC:NASDAQ, Embecta Corp.

EMBC stock overview

Embecta Corp. (EMBC:NASDAQ) closed at $6.02 on November 20, 2026, down 2.75% on the day. The stock trades 59.3% below its 52-week high of $14.81 and 117.3% above its 52-week low of $2.77. Over the past year, it lost 58.9%. Embecta Corp. is part of the Health Care sector.

Key figures

Price
$6.02
Day change
-2.75%
Volume
862,804
Average volume
1,013,367
Market cap
341M+
52-week range
$2.77 – $14.81
50-day average
$6.03
200-day average
$6.09

Price action over the past year

In 252 trading sessions since November 20, 2025, EMBC closed higher on 118 days (47%). Its best day was August 7, 2026 (+26.29%) and its worst was May 5, 2026 (-57.84%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

EMBC news

About Embecta Corp.

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Similar stocks

Find more stocks like EMBC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.